Skip to main content
. 2016 Mar 30;9(2):74–88. doi: 10.1111/cts.12390

Figure 2.

Figure 2

Conceptual representation of nonlinear drug disposition and extrapolation from microdose to therapeutic dose for (a) drugs showing linear PK and (b) drugs showing nonlinear (saturable) PK at therapeutic dose. Width of the blue and orange bars schematically represents ranges of substrate drug concentration after microdose and therapeutic dose, respectively. AUC, area under the concentration‐time curve; CL, clearance; Km, Michaelis‐Menten constant; [S], concentration of a substrate drug S.